13F
中

RCEL AVITA MEDICAL INC

2026Q1 · CUSIP 05380C102 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
77
Δ holders QoQ
+10
Breadth percentile
Top 29%
Whale holders
38
Δ whales
+1
Inst. holding value
$71M
New positions
26
Closed positions
16
Price momentum (1Q)
—
Put / Call
0/2

Breadth history (34 quarters)

2020Q3: Δ+10 · h=44 2020Q4: Δ+9 · h=53 2021Q1: Δ+11 · h=64 2021Q2: Δ+8 · h=72 2021Q3: Δ-4 · h=68 2021Q4: Δ-5 · h=63 2022Q1: Δ+6 · h=69 2022Q2: Δ-12 · h=57 2022Q3: Δ-8 · h=49 2022Q4: Δ+4 · h=53 2023Q1: Δ+20 · h=73 2023Q2: Δ+8 · h=81 2023Q3: Δ+2 · h=83 2023Q4: Δ+2 · h=85 2024Q1: Δ-2 · h=83 2024Q2: Δ-13 · h=70 2024Q3: Δ-3 · h=67 2024Q4: Δ+7 · h=74 2025Q1: Δ+1 · h=75 2025Q2: Δ+5 · h=80 2025Q3: Δ-4 · h=76 2025Q4: Δ-9 · h=67 2026Q1: Δ+10 · h=77 2020Q3: holders=44 2020Q4: holders=53 2021Q1: holders=64 2021Q2: holders=72 2021Q3: holders=68 2021Q4: holders=63 2022Q1: holders=69 2022Q2: holders=57 2022Q3: holders=49 2022Q4: holders=53 2023Q1: holders=73 2023Q2: holders=81 2023Q3: holders=83 2023Q4: holders=85 2024Q1: holders=83 2024Q2: holders=70 2024Q3: holders=67 2024Q4: holders=74 2025Q1: holders=75 2025Q2: holders=80 2025Q3: holders=76 2025Q4: holders=67 2026Q1: holders=77 -20 -10 +0 +10 +20 396590 20Q321Q121Q322Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2023Q1 Top 8% — —

Options Sentiment

Put holders
0
QoQ: -1
Call holders
2
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.56
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+1.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $8M 2022-09-30: $9M 2022-12-31: $9M 2023-03-31: $11M 2023-06-30: $12M 2023-09-30: $14M 2023-12-31: $14M 2024-03-31: $11M 2024-06-30: $15M 2024-09-30: $20M 2024-12-31: $18M 2025-03-31: $19M 2025-06-30: $18M 2025-09-30: $17M 2025-12-31: $18M 2026-03-31: $19M 2022-06-30: EPS 0.25 2022-09-30: EPS 0.22 2022-12-31: EPS 0.22 2023-03-31: EPS -0.37 2023-06-30: EPS -0.41 2023-09-30: EPS -0.34 2023-12-31: EPS -0.28 2024-03-31: EPS -0.73 2024-06-30: EPS -0.60 2024-09-30: EPS -0.62 2024-12-31: EPS -0.44 2025-03-31: EPS -0.53 2025-06-30: EPS -0.38 2025-09-30: EPS -0.46 2025-12-31: EPS -0.37 2026-03-31: EPS -0.35 0M 10M 20M $M -0.80 -0.26 0.28 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 38 2023-03-31: PE 38.1 34 37 40 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)